Charles Schwab Investment Management Inc Neuronetics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Neuronetics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 15,000 shares of STIM stock, worth $66,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$66,000% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding STIM
# of Institutions
109Shares Held
19.5MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$10.1 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$7.65 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$6.24 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.84 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$4.4 Million0.19% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $119M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...